AlexanderWhiteMD

Clinical Trials

• A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis Start of enrollment: 2014 May 01

  Completed

  Phase 2

• A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol Start of enrollment: 2014 Oct 01

  Terminated

  Phase 3

• Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01

  Completed

  Phase 2

• A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia Start of enrollment: 2016 Dec 01

  Completed

  Phase 2

• A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease Start of enrollment: 2017 Jan 31

  Completed

  Phase 1

• Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease Start of enrollment: 2021 Nov 03

  Active, not recruiting

  Phase 3

  Roles: Principal Investigator, Contact

• Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy Start of enrollment: 2019 Sep 20

  Active, not recruiting

  Phase 3

  Roles: Contact

• A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen Start of enrollment: 2023 Mar 13

  Recruiting

  Phase 2

  Roles: Contact

• Open-Label Extension Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Uncontrolled Hypertension Start of enrollment: 2023 Jul 14

  Recruiting

  Phase 2, Phase 3

  Roles: Contact

• Join now to see all